Firm Strategies to Mitigate the Impact of Price Control Regulation

Ajay Bhaskarabhatla
Additional contact information
Ajay Bhaskarabhatla: Erasmus University Rotterdam

Chapter Chapter 7 in Regulating Pharmaceutical Prices in India, 2018, pp 159-194 from Springer

Abstract: Abstract In the previous chapter, we examine the limitations in the design of the 2013 DPCO. It is reasonable to expect that pharmaceutical firms likely to be affected by the regulation undertook actions to mitigate their impact. Because of such strategic actions, regulations, despite being well-intentioned, can sometimes make matters worse (Noll 1989). Have the 2013 DPCO regulations made consumers worse-off than they were before? In this chapter, we examine some of the strategies firms used to mitigate the impact of price controls. We are aware of more strategies than we discuss below. Documenting the larger set of firm strategies is part of our ongoing research agenda.

Date: 2018
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:isbchp:978-3-319-93393-1_7

Ordering information: This item can be ordered from
http://www.springer.com/9783319933931

DOI: 10.1007/978-3-319-93393-1_7

Access Statistics for this chapter

More chapters in India Studies in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().